Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Saved in:
Bibliographic Details
Main Authors SULLIVAN GERARD M, SOUERS ANDREW J, WANG XILU, WANG GARY T, WENDT MICHAEL D, PARK CHEOL-MIN, KUNZER AARON R, ELMORE STEVEN W, HEXAMER LAURA A
Format Patent
LanguageEnglish
Published 13.10.2015
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Bibliography:Application Number: US201213682603